A follow up study of 84 patients with early onset pre-eclampsia (before 37 weeks' gestation) showed a high prevalence of underlying renal disease. Renal abnormalities were found in 33 of the 49 primiparas (67%) and in 22 of the 35 multiparas (63%). Two thirds of the multiparas with pre-eclampsia before 37 weeks with a diagnosis of either essential hypertension or renal disease had recurrent pre-eclampsia. Maternal morbidity and fetal mortality were greater in the group with early onset pre-eclampsia than in a group with late onset disease. Idiopathic pre-eclampsia occurred in 10% of primiparas in the early onset group, whereas it was the main condition in over three quarters of primiparas in the late onset group.
Introduction
Pre-eclampsia is a syndrome of two distinct disease types; it may be purely idiopathic, restricted to and caused by pregnancy, or it may be due to an underlying hypertensive disorder. Chronic renal disease has long been recognised as an important precursor of pre-eclampsia. Nevertheless, its prevalence in pre-eclampsia is uncertain as it may be difficult to detect clinically and there is natural reluctance to perform biopsy for definitive diagnosis. In 1982 Fairley and Birch showed that finding dysmorphic "glomerular" erythrocytes in the urine is a highly specific (93%) and sensitive (99%) indicator of glomerulonephritis.I This simple screening test using phase contrast microscopy has given the opportunity to examine anew the association between chronic renal disease and pre-eclampsia.
We present a preliminary report of the findings of a special clinic established at the Mercy Maternity Hospital, Melbourne, for the follow up investigation of patients with pre-eclampsia.
Patients and methods
Patients referred to the follow up clinic include particularly those with early onset (before 37 weeks of gestation) pre-eclampsia and those with severe or recurrent pre-eclampsia of later pregnancy. Over 18 months 84 women with early onset and 94 with late onset pre-eclampsia attended the clinic and are the subjects of this study. These patients accounted for roughly half of all patients delivered at the hospital during the period with early onset pre-eclampsia. The remaining patients either were not referred to the clinic or were unable to return for three separate visits owing to domestic commitments or geographical difficulties.
Pre-eclampsia was diagnosed after 20 weeks ofgestation by the presence of at least two of the following: blood pressure 140/90 mm Hg or higher on two or more occasions, generalised oedema, and proteinuria without evidence of contamination or urinary infection. At this hospital the prevalence of preeclampsia is 10%; a quarter of the cases are diagnosed before 37 weeks of gestation, so that the incidence of early onset pre-eclampsia is 2-5% of all deliveries.
At least two 24 hour estimations of creatinine clearance and total urinary protein were performed together with measurements of serum electrolyte and plasma urea and creatinine concentrations in the postpartum period. Phase contrast microscopy was used to detect glomerular haematuria in three separate midstream specimens of urine from each patient. Renal biopsy was done if the glomerular erythrocyte count exceeded 20x 106/I (normal 8 x 106/1) six weeks or more after delivery, biopsy being delayed until at least six months post partum to allow the morphological changes due to pre-eclampsia to subside. Biopsy specimens were processed for light, immunofluorescence, and electron microscopy. All patients with abnormal findings on urine microscopy had intravenous pyelography. Intravenous pyelograms were also obtained from patients whose urinary findings were normal but in whom there was clinical suspicion of underlying renal tract disorder-for example, a history of enuresis, recurrent urinary tract infection, or family history of polycystic kidney disease.
Essential hypertension was diagnosed when the findings from phase contrast microscopy and pyelography were normal and blood pressure was raised before 20 weeks ofgestation or between pregnancies or persisted for at least three months after delivery.
Results were analysed according to parity, time of onset and severity of pre-eclampsia, and the prevalence of underlying disease. B U IHLE, 10, JANUARY 1987 Results In this series pre-eclampsia occurring before 37 weeks of gestation (range 24-36 weeks) was a more severe disease than that occurring after 37 weeks (range 3742 weeks) (table I). In addition, placental dysfunction (subnormal oestriol excretion), low birth weight, and perinatal death were all significantly more common in the early onset group (table I) . S Based on birth weight for period of gestation.
Chronic renal disease or essential hypertension was diagnosed in 76 (90%) of the women with early onset pre-eclampsia (44 of the 49 primiparas, 32 of the 35 multiparas) (table II). In the late onset group over three quarters ofthe primiparas (57 of 73) were considered to have idiopathic or pregnancy induced pre-eclampsia, 11 (15%) being found to have chronic renal disease, by contrast, 17 (81%) ofthe multiparas in this group had an associated causal disease.
these patients had normal renal function six weeks after delivery but five with IgA glomerulonephritis remained hypertensive.
Two primiparas were found to have systemic lupus erythematosus (revised American Rheumatism Association criteria); one multipara was known to have had this disease for one year before the index pregnancy and renal biopsy showed focal necrotising glomerulonephritis consistent with the disease. Surprisingly, morphological changes consistent with diabetic nephropathy were found in three patients with gestational diabetes. Equally surprisingly, glucose tolerance was normal in one and merely impaired (World Health Organisation criteria) in the two others when tested six weeks after delivery. Hypertension persisted in two of these patients.
The eight cases of reflux nephropathy and the two of polycystic kidney disease found by intravenous pyelography had not been diagnosed before.
Essential hypertension was diagnosed in 21 patients (25%) with early onset pre-eclampsia. Five ofthe 11 primiparas gave a history ofhypertension when taking oral contraceptives. All 10 multiparas had had pre-eclampsia in past pregnancies, were hypertensive during the first trimester of the index pregnancy, and showed changes ofhypertensive retinopathy consistent with longstanding disease.
Sixteen ofthe 94 patients with late onset pre-eclampsia (17%) had chronic renal disease (table II) . There were three with known reflux nephropathy and seven with diagnosed glomerulonephritis. The other six patients had glomerular haematuria; in four biopsy showed IgA nephropathy.
Discussion
Though only about half of the known patients who developed early onset pre-eclampsia were available for follow up evaluation, this study shows that the presence of a renal abnormality predisposing to pre-eclampsia was much more common in the early onset group both in primiparas and in multiparas. Not only were these patients suffering from a more severe form of pre-eclampsia compared with the late onset group but maternal morbidity (coagulopathy, more severe hypertension) and fetal mortality were Patients with mesangial IgA nephropathy in pregnancy are far more likely to show segmental lesions of hyaline degeneration and sclerosis than are non-pregnant patients with this immune complex disease.' As IgA nephropathy tends to progress by the formation of segmental lesions, pregnancy may accelerate the formation of this lesion. This was shown by one of our patients with recurrent early onset pre-eclampsia and appreciable deterioration in renal function (creatinine concentration 50-110 ,umol/l; 0-6-1-2 mg/100 ml) for whom histological findings were available before and immediately after the pregnancy.
In the early onset group eight of the 10 multiparas with IgA disease had suffered pre-eclampsia in previous pregnancies. After these earlier pregnancies they had become normotensive but phase contrast microscopy had not been performed. The presence of appreciable microscopic haematuria in subsequent pregnancies suggests that their previous episodes of pre-eclampsia were very likely related to IgA disease.
In 25 patients with IgA nephropathy 21 did not have appreciable proteinuria post partum and only five continued to be hypertensive, while renal function was normal in all. This emphasises that normal renal function and absence of proteinuria post partum do not exclude underlying renal disease in women with recurrent or early onset pre-eclampsia.
Not all patients with IgA nephropathy who become pregnant, however, are destined to develop pre-eclampsia. Our patients were selected because of problems related to pregnancy. Katz et al found a low incidence of pre-eclampsia in women with known kidney disease.8 Nevertheless, a previous study suggested that the presence of IgA nephropathy and pre-eclampsia has a high association, with 62% of pregnancies complicated by this condition.' Again, however, these patients were referred only because of problems related to pregnancy.
We were surprised by biopsy findings consistent with diabetic nephropathy in the three patients who had gestational diabetes, since one had required insulin during pregnancy to maintain normoglycaemia. Gonzalez-Gonzalez et al reported similar findings in eight women with mild diabetes in pregnancy, four of whom developed pre-eclampsia.9 All eight had biopsy changes consistent with diabetic nephropathy.
This study has shown that a presumptive diagnosis of true or idiopathic pre-eclampsia is likely to be correct only in primiparas who develop the signs late in pregnancy. In all others a careful search for an underlying medical disorder has a high probability of yielding a positive finding, as shown by a 90% prevalence of causative disease (roughly two thirds renal) in this short term follow up investigation. Multiparous patients with pre-eclampsia (early or late) should also always be thoroughly investigated. Pre-eclampsia should not be taken as a final diagnosis. It is a pregnancy related syndrome only in the small group with a late onset (greater than 37 weeks of gestation).
Definitive diagnosis enables a more informed prognosis to be given for future pregnancies. Nevertheless, reliance on only biochemical indices of renal function in order to detect renal impairment will underestimate the presence of chronic renal disease; careful phase contrast microscopy should therefore be carried out, which is cheap and a very useful screening test with a high sensitivity and specificity and no false positivity. This simple test also allows confident selection of patients who might be considered for renal biopsy.
Life threatening sickle chest syndrome treated with extracorporeal membrane oxygenation D S GILLETT, K E J GUNNING, E H SAWICKA, A J BELLINGHAM, R J WARE Abstract A young West Indian woman with established sickle cell disease developed a severe episode of sickle chest syndrome. Conventional treatment including exchange transfusions and mechanical ventilation was to no avail, and an infusion of epoprostenol also failed to halt her worsening condition. When her arterial oxygen tension (Pao2) had fallen to 6.5 kPa (49 mmHg) extracorporeal membrane oxygenation was instituted.
Within two days her Pao2 was greatly improved (maximum 11-6 kPa; 87 mmHg), and by the sixth day pulmonary vascular resistance was reduced and angiography showed reperfusion of many vessels. The patient recovered and six months later showed a transfer factor close to the predicted range and normal spirometric values.
Extracorporeal membrane oxygenation should be considered for severe sickle chest syndrome when conventional methods of artificial ventilation fail.
Introduction
Sickle chest syndrome is a common complication of sickle cell disease, presenting with chest pain, fever, and leucocytosis. The pathophysiology is uncertain, and some patients become progressively hypoxic and die despite conventional management and
